Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic abnormalities in scleroderma

E P Amento1

  • 1Molecular Medicine Research Institute, Mountain View, CA 94043, USA.

Seminars in Cutaneous Medicine and Surgery
|March 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional inhibition of stromelysin by interferon-gamma in normal human fibroblasts is mediated by the AP-1 domain.

Journal of cellular biochemistry·1999
Same author

Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.

The Journal of rheumatology·1998
Same author

The role of relaxin in glycodelin secretion.

The Journal of clinical endocrinology and metabolism·1997
Same author

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

The Journal of clinical investigation·1996
Same author

Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1.

The Journal of biological chemistry·1996
Same author

Connective tissue metabolism in scleroderma, including cytokines.

Current opinion in rheumatology·1996

Scleroderma involves diverse immune system abnormalities alongside vascular and mesenchymal cell issues, leading to organ dysfunction. New research into immune regulation, self-antigens, and fetal cells may clarify this complex autoimmune disease.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathophysiology

Background:

  • Scleroderma exhibits complex immune system abnormalities.
  • These abnormalities interact with vascular and mesenchymal cells.
  • This interaction contributes to organ dysfunction and disease manifestation.

Purpose of the Study:

  • To explore recent insights into scleroderma pathogenesis.
  • To investigate novel immune regulatory pathways.
  • To understand the role of self-antigens and persistent fetal cells.

Main Methods:

  • Review of current immunological and pathogenetic research.
  • Analysis of immune reactivity to self-antigens.
  • Exploration of the association between persistent fetal cells and disease expression.

Related Experiment Videos

Main Results:

  • Immune system abnormalities are central to scleroderma.
  • Vascular and mesenchymal cell abnormalities are key contributors.
  • Novel pathways and factors like persistent fetal cells offer new understanding.

Conclusions:

  • Understanding scleroderma requires examining diverse immune, vascular, and cellular interactions.
  • Further research into immune regulation and specific cellular components is crucial.
  • These insights may unlock new therapeutic strategies for scleroderma.